Hormone and Metabolic Research

LinksSchließen

Referenz

Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP. Diabetes Multicenter Research Group.
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

Arch Intern Med 2002;
162: 1568-1576

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: